AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Recordati Industria Chimica e Farmaceutica

Transaction in Own Shares Aug 27, 2024

4056_rns_2024-08-27_6ef36ef7-58ad-49c4-9081-c3f6e832a208.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

RECORDATI: UPDATE ON THE EXECUTION OF THE SHARE BUY-BACK PROGRAM

Milan, 27 th August 2024 – Within the Recordati's share buy-back program communicated to the market on 9th May 2024 and initiated on 10th May 2024, as per authorization granted by the Shareholders' Meeting held on 22nd April 2024, with the object of the servicing of current and future stock option / performance shares plans in favour of the Recordati Group's management or sharebased incentive plans that might be approved by the Company in the future, the Company communicates the following purchase transactions of Recordati shares pursuant to art. 2, paragraph 3, of the EU Delegated Regulation 2016/1052/EU, on the basis of the information provided by UBS Europe SE as intermediary in charge of executing, in full independency, the share buy-back program on behalf of the Company.

Aggregate details of daily transactions made from 19 th to 23rd August 2024 in Recordati ordinary shares (ISIN IT0003828271) are as follows:

SUMMARY OF PURCHASE TRANSACTIONS
Date Type of Quantity Weighted average price Exchange
Transaction (Euro)
20/08/2024 Purchase 9,585 50.3779 MTA
TOTAL 9,585 50.3779

The details of all the purchase transactions carried out in the period indicated above are reported in the following pages.

On 23rd August 2024, the Company held no. 2,923,886 treasury shares which amount to 1.398% of the current share capital.

Recordati is an international pharmaceutical group listed on the Italian Stock Exchange (XMIL: REC), with roots dating back to a family-run pharmacy in Northern Italy in the 1920s. We are uniquely structured to provide treatments across specialty and primary care, and rare diseases. Our fully integrated operations span clinical development, chemical and finished product manufacturing, commercialisation and licensing. We operate in approximately 150 countries across EMEA, the Americas and APAC with over 4,450 employees. We believe that health is a fundamental right, not a privilege. Today, our purpose of "unlocking the full potential of life" aims at empowering individuals to live life to the fullest, whether addressing common health challenges or the rarest.

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office Via Matteo Civitali, 1 20148 Milano, Italy Tel. +39 02 487871 Fax +39 02 40073747 www.recordati.com

Share Capital € 26.140.644,50 fully paid-up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l

Investor Relations

Eugenia Litz +44 7824 394 750 [email protected]

Media Relations

ICR Healthcare US: Alexis Feinberg +1 203 939 2225 [email protected] Lucia Abbatantuoni +39 337 1025645 [email protected]

ICR Healthcare UK, Europe & Rest of World: Chris Welsh +44 7793 240 916 [email protected]

Attachment: daily details of transactions

Date Time (GMT) Currency Exchange Price Quantity
20/08/2024 08:05:12 EUR MTA 50,5000 245
20/08/2024 12:42:32 EUR MTA 50,5000 171
20/08/2024 12:42:32 EUR MTA 50,5000 261
20/08/2024 12:52:31 EUR MTA 50,5000 352
20/08/2024 12:52:31 EUR MTA 50,5000 270
20/08/2024 12:52:31 EUR MTA 50,5000 231
20/08/2024 12:52:31 EUR MTA 50,5000 227
20/08/2024 12:52:31 EUR MTA 50,5000 74
20/08/2024 12:52:31 EUR MTA 50,5000 270
20/08/2024 12:52:31 EUR MTA 50,5000 239
20/08/2024 12:52:31 EUR MTA 50,5000 237
20/08/2024 12:52:31 EUR MTA 50,5000 223
20/08/2024 12:55:07 EUR MTA 50,4500 233
20/08/2024 13:21:33 EUR MTA 50,2500 125
20/08/2024 13:21:33 EUR MTA 50,2500 244
20/08/2024 13:21:33 EUR MTA 50,2500 253
20/08/2024 13:21:33 EUR MTA 50,2500 245
20/08/2024 13:21:33 EUR MTA 50,2500 220
20/08/2024 13:21:33 EUR MTA 50,2500 242
20/08/2024 13:21:33 EUR MTA 50,2500 304
20/08/2024 13:21:33 EUR MTA 50,2500 256
20/08/2024 13:21:33 EUR MTA 50,2500 229
20/08/2024 13:21:33 EUR MTA 50,2500 247
20/08/2024 13:21:33 EUR MTA 50,2500 233
20/08/2024 13:21:33 EUR MTA 50,2500 270
20/08/2024 13:21:33 EUR MTA 50,2500 265
20/08/2024 13:21:33 EUR MTA 50,2500 270
20/08/2024 13:21:33 EUR MTA 50,2500 227
20/08/2024 13:21:33 EUR MTA 50,2500 244
20/08/2024 13:21:33 EUR MTA 50,2500 491
20/08/2024 13:21:33 EUR MTA 50,2500 220
20/08/2024 13:38:48 EUR MTA 50,4500 248
20/08/2024 15:38:02 EUR MTA 50,5000 197
20/08/2024 15:38:02 EUR MTA 50,5000 70
20/08/2024 15:38:02 EUR MTA 50,5000 269
20/08/2024 15:38:02 EUR MTA 50,5000 237
20/08/2024 15:38:02 EUR MTA 50,5000 255
20/08/2024 16:22:40 EUR MTA 50,5000 262
20/08/2024 16:22:40 EUR MTA 50,5000 263
20/08/2024 16:25:52 EUR MTA 50,5000 166

Talk to a Data Expert

Have a question? We'll get back to you promptly.